» Articles » PMID: 25298073

Endarteritis Obliterans in the Pathogenesis of Buerger's Disease from the Pathological and Immunohistochemical Points of View

Overview
Journal Circ J
Date 2014 Oct 10
PMID 25298073
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Buerger's disease (thromboangiitis obliterans) is considered to be a nonatherosclerotic, inflammatory, and vaso-occlusive disease, although the details of the mechanisms of pathogenesis remain unknown. The occurrence of the disease is strongly related to tobacco abuse and its progression is closely linked to continued smoking. The purpose of this review article is to demonstrate the pathological characteristics of arteries affected with Buerger's disease from a possible immunoreactive point of view. In addition, we present the mechanisms for preserving the architecture of the arterial wall in affected vasculatures. Thereafter, we discuss the possibility that the pathogenesis of Buerger's disease is a type of endarteritis obliterans, deeply connected to the Notch pathway, distinct from arteriosclerosis obliterans and other vasculitides.

Citing Articles

Comparative Analysis of Transcriptome Profiles in Patients with Thromboangiitis Obliterans.

Oztan G, Bozbuga N, Issever H, Oguz F, Caniaz I, Yaziksiz N Genes (Basel). 2024; 15(1).

PMID: 38275601 PMC: 10815726. DOI: 10.3390/genes15010019.


Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.

Zou C, Liu L, Huang C, Hu S Front Pharmacol. 2022; 13:1018438.

PMID: 36304158 PMC: 9592700. DOI: 10.3389/fphar.2022.1018438.


An Unusual Case of Buerger's Disease in a Pregnant Female.

Karena Z, Mehta A, Rao R, Gowda N, Gadhia V Cureus. 2022; 14(8):e28382.

PMID: 36171849 PMC: 9508790. DOI: 10.7759/cureus.28382.


Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia.

Jiang X, Liu H, Pan T, Gu S, Fang Y, Wei Z Front Cardiovasc Med. 2021; 8:769472.

PMID: 34938786 PMC: 8687358. DOI: 10.3389/fcvm.2021.769472.


Three-year outcomes of peripheral blood mononuclear cells vs purified CD34 cells in the treatment of angiitis-induced no-option critical limb ischemia and a cost-effectiveness assessment: A randomized single-blinded noninferiority trial.

Liu H, Pan T, Fang Y, Fang G, Liu Y, Jiang X Stem Cells Transl Med. 2021; 10(5):647-659.

PMID: 33399273 PMC: 8046046. DOI: 10.1002/sctm.20-0033.